Judy Dering
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 5
- Peptidase Inhibition and Analysis 3
-
- PI3K/AKT/mTOR signaling in cancer 4
- Melanoma and MAPK Pathways 3
- Co-authors
- Dennis J. Slamon (20 shared papers)Richard S. Finn (14 shared papers)Charles Ginther (11 shared papers)Amrita J. Desai (7 shared papers)Ondrej Kalous (3 shared papers)Dylan F. Conklin (3 shared papers)Isan Chen (1 shared paper)David J. Cohen (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (4 papers)Breast Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Judy Dering
33 papers receiving 4.3k citations
Judy Dering's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 2.2k
- Cancer Research 807
- Pulmonary and Respiratory Medicine 1.4k
- Reproductive Medicine 348
- Genetics 285
Countries citing papers authored by Judy Dering
This map shows the geographic impact of Judy Dering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Dering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Dering more than expected).
Fields of papers citing papers by Judy Dering
This network shows the impact of papers produced by Judy Dering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Dering. The network helps show where Judy Dering may publish in the future.
Co-authors
The 25 scholars most cited alongside Judy Dering, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro Hit paper breakdown → | 2009 | 1166 |
| 2 | 2008 | 376 | |
| 3 | 2007 | 344 | |
| 4 | 2014 | 309 | |
| 5 | 2013 | 293 | |
| 6 | 2011 | 258 | |
| 7 | 2010 | 215 | |
| 8 | 2009 | 152 | |
| 9 | 2009 | 142 | |
| 10 | 2014 | 117 | |
| 11 | 2008 | 98 | |
| 12 | 2010 | 93 | |
| 13 | 2013 | 93 | |
| 14 | 2009 | 87 | |
| 15 | 2013 | 81 | |
| 16 | 2008 | 68 | |
| 17 | 2013 | 59 | |
| 18 | 2010 | 52 | |
| 19 | 2013 | 52 | |
| 20 | 2020 | 50 |
About Judy Dering
Judy Dering is a scholar working on Oncology, Molecular Biology, Cell Biology, Hematology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 4.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Microtubule and mitosis dynamics (3 papers), Peptidase Inhibition and Analysis (3 papers), Melanoma and MAPK Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (807 citations), Pulmonary and Respiratory Medicine (1.4k citations), Reproductive Medicine (348 citations) and Genetics (285 citations). Judy Dering has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Dennis J. Slamon, Richard S. Finn, Charles Ginther, Amrita J. Desai, Ondrej Kalous, Dylan F. Conklin, Isan Chen, David J. Cohen, Mohammad S. Atefi and Camilla Fowst. Their work appears in journals such as Breast Cancer Research and Treatment, Breast Cancer Research, Journal of Clinical Oncology, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.